Jazz Pharmaceuticals plc’s recent filing unveils that its Chairman & CEO COZADD BRUCE C unloaded Company’s shares for reported $0.11 million on Jul 01 ’25. In the deal valued at $107.63 per share,1,000 shares were sold. As a result of this transaction, COZADD BRUCE C now holds 436,973 shares worth roughly $47.69 million.
Then, COZADD BRUCE C bought 1,000 shares, generating $107,630 in total proceeds.
Before that, COZADD BRUCE C sold 500 shares. Jazz Pharmaceuticals plc shares valued at $55,000 were divested by the Chairman & CEO at a price of $110.00 per share. As a result of the transaction, COZADD BRUCE C now holds 437,973 shares, worth roughly $47.8 million.
UBS upgraded its Jazz Pharmaceuticals plc [JAZZ] rating to a Buy from a a Neutral in a research note published on March 07, 2025; the price target was increased to $179 from $145. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in late February from “an Overweight” to “a Neutral”. Wells Fargo also remained covering JAZZ and has increased its forecast on February 13, 2025 with a “an Overweight” recommendation from previously “an Equal weight” rating. Morgan Stanley revised its rating on December 12, 2024. It rated JAZZ as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 1.42% to $109.13. Over the last five days, the stock has gained 2.84%. Jazz Pharmaceuticals plc shares have risen nearly 5.41% since the year began. Nevertheless, the stocks have fallen -11.38% over the past one year. While a 52-week high of $148.06 was reached on 02/26/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 107.48, which if violated will result in even more drops to 105.84. On the upside, there is a resistance level at 111.14. A further resistance level may holdings at 113.16.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-06-13, dropping by -0.12 million shares to a total of 5.83 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 5.95 million shares. There was a decline of -2.11%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 05, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $169 price target.
